Non-interest operating expenses in Q1 Fiscal 2013 totaled $1,291,287 versus $581,029 for Q1 Fiscal 2012, an overall increase of 122%. Of the $710,258 increase, $403,492 was attributable to the addition of the new mHealth division, while related acquisition costs, increased patent fees and higher share-based compensation accounted for the balance of the increased expenses. The Company remains committed to controlling all discretionary non-interest spending until operating cash flow improves and
new financing is arranged;
shorts will be coming for this, financing sounds like its coming around the corner. if you are looking to jump in or average down, perhaps now is not the time..